Literature DB >> 20597109

Interleukin-1 antagonism in acute gout: is targeting a single cytokine the answer?

Tuhina Neogi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20597109      PMCID： PMC2952045          DOI： 10.1002/art.27635

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN： 0004-3591


× No keyword cloud information.
  24 in total

1.  Epidemiology of gout: is the incidence rising?

Authors:  Emvalee Arromdee; Clement J Michet; Cynthia S Crowson; W Michael O'Fallon; Sherine E Gabriel
Journal:  J Rheumatol       Date:  2002-11       Impact factor: 4.666

Review 2.  Effectiveness of interventions for the treatment of acute and prevention of recurrent gout--a systematic review.

Authors:  S Sutaria; R Katbamna; M Underwood
Journal:  Rheumatology (Oxford)       Date:  2006-04-21       Impact factor: 7.580

Review 3.  EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT).

Authors:  W Zhang; M Doherty; T Bardin; E Pascual; V Barskova; P Conaghan; J Gerster; J Jacobs; B Leeb; F Lioté; G McCarthy; P Netter; G Nuki; F Perez-Ruiz; A Pignone; J Pimentão; L Punzi; E Roddy; T Uhlig; I Zimmermann-Gòrska
Journal:  Ann Rheum Dis       Date:  2006-05-17       Impact factor: 19.103

4.  Gout-associated uric acid crystals activate the NALP3 inflammasome.

Authors:  Fabio Martinon; Virginie Pétrilli; Annick Mayor; Aubry Tardivel; Jürg Tschopp
Journal:  Nature       Date:  2006-01-11       Impact factor: 49.962

5.  Frequency and predictors of inappropriate management of recurrent gout attacks in a longitudinal study.

Authors:  Tuhina Neogi; David J Hunter; Christine E Chaisson; Donald Allensworth-Davies; Yuqing Zhang
Journal:  J Rheumatol       Date:  2005-11-01       Impact factor: 4.666

6.  Suboptimal physician adherence to quality indicators for the management of gout and asymptomatic hyperuricaemia: results from the UK General Practice Research Database (GPRD).

Authors:  T R Mikuls; J T Farrar; W B Bilker; S Fernandes; K G Saag
Journal:  Rheumatology (Oxford)       Date:  2005-05-03       Impact factor: 7.580

7.  Gout epidemiology: results from the UK General Practice Research Database, 1990-1999.

Authors:  T R Mikuls; J T Farrar; W B Bilker; S Fernandes; H R Schumacher; K G Saag
Journal:  Ann Rheum Dis       Date:  2005-02       Impact factor: 19.103

8.  Increasing prevalence of gout and hyperuricemia over 10 years among older adults in a managed care population.

Authors:  Katrine L Wallace; Aylin A Riedel; Nancy Joseph-Ridge; Robert Wortmann
Journal:  J Rheumatol       Date:  2004-08       Impact factor: 4.666

9.  Neonatal-onset multisystem inflammatory disease responsive to interleukin-1beta inhibition.

Authors:  Raphaela Goldbach-Mansky; Natalie J Dailey; Scott W Canna; Ana Gelabert; Janet Jones; Benjamin I Rubin; H Jeffrey Kim; Carmen Brewer; Christopher Zalewski; Edythe Wiggs; Suvimol Hill; Maria L Turner; Barbara I Karp; Ivona Aksentijevich; Frank Pucino; Scott R Penzak; Margje H Haverkamp; Leonard Stein; Barbara S Adams; Terry L Moore; Robert C Fuhlbrigge; Bracha Shaham; James N Jarvis; Kathleen O'Neil; Richard K Vehe; Laurie O Beitz; Gregory Gardner; William P Hannan; Robert W Warren; William Horn; Joe L Cole; Scott M Paul; Philip N Hawkins; Tuyet Hang Pham; Christopher Snyder; Robert A Wesley; Steven C Hoffmann; Steven M Holland; John A Butman; Daniel L Kastner
Journal:  N Engl J Med       Date:  2006-08-10       Impact factor: 91.245

10.  Comparison of oral prednisolone/paracetamol and oral indomethacin/paracetamol combination therapy in the treatment of acute goutlike arthritis: a double-blind, randomized, controlled trial.

Authors:  Chi Yin Man; Ian T F Cheung; Peter A Cameron; Timothy H Rainer
Journal:  Ann Emerg Med       Date:  2007-02-05       Impact factor: 5.721
View more
  6 in total

Review 1.  Difficult-to-treat gouty arthritis: a disease warranting better management.

Authors:  Naomi Schlesinger
Journal:  Drugs       Date:  2011-07-30       Impact factor: 9.546

Review 2.  Trends in the Contribution of Genetic Susceptibility Loci to Hyperuricemia and Gout and Associated Novel Mechanisms.

Authors:  Jianan Zhao; Shicheng Guo; Steven J Schrodi; Dongyi He
Journal:  Front Cell Dev Biol       Date:  2022-06-23

Review 3.  Mechanistic aspects of inflammation and clinical management of inflammation in acute gouty arthritis.

Authors:  Bruce N Cronstein; Prashanth Sunkureddi
Journal:  J Clin Rheumatol       Date:  2013-01       Impact factor: 3.517

4.  Canakinumab relieves symptoms of acute flares and improves health-related quality of life in patients with difficult-to-treat Gouty Arthritis by suppressing inflammation: results of a randomized, dose-ranging study.

Authors:  Naomi Schlesinger; Marc De Meulemeester; Andrey Pikhlak; A Eftal Yücel; Dominik Richard; Valda Murphy; Udayasankar Arulmani; Peter Sallstig; Alexander So
Journal:  Arthritis Res Ther       Date:  2011-03-25       Impact factor: 5.156

5.  Canakinumab reduces the risk of acute gouty arthritis flares during initiation of allopurinol treatment: results of a double-blind, randomised study.

Authors:  Naomi Schlesinger; Eduardo Mysler; Hsiao-Yi Lin; Marc De Meulemeester; Jozef Rovensky; Udayasankar Arulmani; Alison Balfour; Gerhard Krammer; Peter Sallstig; Alexander So
Journal:  Ann Rheum Dis       Date:  2011-05-03       Impact factor: 19.103

Review 6.  Interleukin-1 antagonists in the treatment of autoinflammatory syndromes, including cryopyrin-associated periodic syndrome.

Authors:  Pierre Quartier
Journal:  Open Access Rheumatol       Date:  2011-01-18
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.